Robert F. Kennedy Jr., Trump’s Health Secretary pick, just launched a bombshell move to ban Big Pharma ads on TV, and it’s a direct strike at the heart of networks like CNN, MSNBC, and CNBC—leaving Trump supporters cheering and the left in panic.
In a video, Patrick Bet-David exposes the dirty truth: “Big Pharma is keeping Cable TV in business. 75% of ad revenue on cable television comes from the Pharmaceutical Industry.” That’s $4.5 billion in 2022 alone, per MediaRadar, propping up these networks while they push drugs like Ozempic.
Video:
The U.S. and New Zealand are the only two countries allowing direct-to-consumer pharma ads, and RFK Jr.’s plan, announced on March 24, 2025, aims to end Big Pharma’s stranglehold on media narratives, per Hollywood Reporter.
This isn’t just a policy shift—it’s a war on the media’s lifeblood. @lisalovesshells on X confirms, “Big Pharma is the media’s biggest customer”, echoing Bet-David’s claim:
CNN alone raked in $19.9 million from pharma ads in 2018, per Adweek, while GroupM predicts a 3.4% ad revenue drop for cable in 2025 if RFK Jr. succeeds. RFK Jr.’s “Make America Healthy Again” (MAHA) movement, backed by Trump, targets the 40% of Americans who trust TV drug ads, per a 2024 KFF poll, despite buried side effects. Web reports from NPR and Stat News highlight the legal hurdles—First Amendment challenges loom—but RFK Jr.’s long-standing fight against Big Pharma, per Children’s Health Defense, shows he’s ready.
